Results 81 to 90 of about 1,049,804 (214)

Current research for a vaccine against Lassa hemorrhagic fever virus

, 2018
Bryce M Warner,1 David Safronetz,2 Derek R Stein2 1Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada; 2Zoonotic Diseases and Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada ...
Safronetz D, Warner BM, Stein DR
core  

Infection of type I interferon receptor-deficient mice with various old world arenaviruses: a model for studying virulence and host species barriers.

PLoS ONE, 2013
Lassa virus causes hemorrhagic Lassa fever in humans, while the related Old World arenaviruses Mopeia, Morogoro, and Mobala are supposedly apathogenic to humans and cause only inapparent infection in non-human primates.
Toni Rieger, Doron Merkler, Stephan Günther   +2 more
doaj   +1 more source

Identifizierung unbekannter Funktionen im Lassa-Virus L-Protein

, 2010
The central domain of the 200-kDa Lassa virus L protein is a putative RNA-dependent RNA polymerase. N- and C-terminal domains may harbor enzymatic functions important for viral mRNA synthesis, including capping enzymes or cap-snatching endoribonucleases.
Lelke, Michaela
core  

Rodent control strategies and Lassa virus: some unexpected effects in Guinea, West Africa

Emerging Microbes and Infections
The Natal multimammate mouse (Mastomys natalensis) is the host of Lassa mammarenavirus, causing Lassa haemorrhagic fever in West Africa. As there is currently no operational vaccine and therapeutic drugs are limited, we explored rodent control as an ...
Joachim Mariën, Mickaël Sage, Umaru Bangura, Alicia Lamé, Michel Koropogui, Toni Rieger, Barré Soropogui, Moussa Douno, N’Faly Magassouba, Elisabeth Fichet-Calvet   +9 more
doaj   +1 more source

Lassa fever [PDF]

Lassa fever is an acute viral illness that occurs in west Africa. The illness was discovered in 1969 when two missionary nurses died in Nigeria. The virus is named after the town in Nigeria where the first cases occurred. The virus, a member of the virus

core  

Incidence of symptomatic Lassa virus infection in West African countries (Enable 1.0 Lassa Research Study): a prospective, multisite, cohort study

The Lancet Global Health
Summary: Background: Lassa fever vaccine trials are hampered by knowledge gaps on disease incidence, at-risk populations, sequelae, and transmission risks.
Abdel Mecit Dicko Issifou, Akpenè Ruth Esperencia Deha, Anges Yadouleton, Ansia Isiace Yanclo, Ayola Akim Adegnika, Carine Tchibozo, Enagnon Junior Juvenal Prince Honvou, Enagnon Parsifal Marie Alexandre Logbo, Francis Houeya, Gildas Hounkanrin, Jeannot Zinsou, Josiane Honkpehedji, Olaniyi Abil Adegnika, Olouyomi Scherif Adegnika, Praise Adewumi, Selidji Todagbe Agnandji, Yvette Badou, Adebola Olayinka, David Dogo, Kamji Jan, Khadijah Ojirobe, Lynn Sase, Michael Adebisi, Onikepe Folarin, Adama Ahmad, Adesola Adeleye, Chiedozie Ojide, Chima Ihemeje, Eugene Samuel Bwede, Iliya Botson, Jessica Onyema, Munzali Shamsu, Nkiruka Lynda Uzoebo, Osarenmwinda Omobude, Sa’adatu Aliyu Abubakar, Zacchaeus Adejuyigbe, Abdel Mécit Odia Ikponwonsa, Cyril Erameh, Danny Asogun, Ekaete Tobin, Ephraim Ogbaini-Emovon, Esther Okogbenin, Faustina Blackie, Francis Erah, George Akpede, Gloria Eifediyi, Ivie Airefetalor, Jacqueline Ehimuan, Joseph Okoeguale, Martha Okonofua, Maxy Odike, Monday Agbonifo, Nosa Akpede, Reuben Eifediyi, Sylvanus Okogbenin, Austin A Osagbaekhoe, Bamidele Funbi, Chukwuyem Abejegah, Ireneh Ronke, Johnson Etafo, Liasu Adeagbo Ahmed, Macdonald Onyechi, Nelson A Adedosu, Oladele Oluwafemi Ayodeji, Andrea Bernasconi, Matthias Borchert, Abu Augustine, Benedict N Azuogu, Chiedozie Ojide, Ekeh Matthew, Ifeanyi Nwator, Ngozo Ugwu, Nnenna Ajayi, Odeh Elizabeth, Okoro Sylvanus, Onoh Robinson, Rosemary Duruiheoma, Venatious Onyia, Aminata Ndiaye, Anton Camacho, Boni-Maxime Ale, Denis Opio, Eric Youm, Hugo Soubrier, Mark Ndifon, Patrick Barks, Paul Campbell, Robert Nsaibirni, Souna Garba, Yves Amevoin, Christine Jacobsen, Elisabeth Fichet Calvet, Guiditta Annibaldis, Nathalie J Vielle, Ndapewa Ithete, Sophie Duraffour, Stephan Günther, Abigail Morrison, Alexander Samposon, Alfred Flomo, Aloysius Weah Duke, Amara Fofana, Carwolo Peru, Catherine Nimely, Catherine Sumo, David A Wohl, Emmanuel Kerkula, Hanan Shuayto, Jean Demarco, Jefferson Sibley, Laurel Zdanski, Eleanor Watts, Sam Livingston, Sandrena Frischer, Stanley Kerkula, Susan Sunay, Thomas Remont, Thomas Sumo, William A Fischer, II, David A Wohl, McKenzie Colt, Crystal Y Zheng, Emily J Engel, John S Schieffelin, Nell G Bond, Robert F Garry, Alhaji Jalloh, Donald Samuel Grant, Foday Alhasan, John D Sandi, Lansana Kanneh, Mambu Momoh, Mohamed Harding, Mohamed K Saio, Robert Samuels, Tiangay Kallon, Christian T Happi, Onikepe Folarin, Carol Kagia, Patrick Suykerbuyk, Suzanne Penfold, Aissatou Bah, Amadou Dore, Bakary Sylla, Barrè Soropgui, Fanta Berete, Jacob Camara, Moussa Conde, N’Faly Magassouba, Lisa Elisabeth Diallo, Margaret Williams, Philip Ayivor, Ahmadou Dore, Alpha Mamodou Diallo, Alpha Midiaou Sow, Bakary Sylla, Gnoumé Camara, Jacob Camara, Mamadou Lamine Barry, Moussa Conde, Moussa Soka Douno, Tamba Jacques Millimouno, Dory Kovacs, J Gabrielle Breugelmans, Henshaw Mandi, Roice Fulton, Solomon Abebe Yimer, Sophie Warren   +167 more
doaj   +1 more source

Viral hemorrhagic fevers Lassa virus: (Week 17) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending April 29, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Lassa virus, Viral hemorrhagic fevers cases.

core  

CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaques

JCI Insight
Empirical data from survivors of Lassa fever and experimental disease modeling efforts, particularly those using mouse models, are at odds with respect to T cell–mediated pathogenesis.
Jérémie Prévost, Nikesh Tailor, Geoff Soule, Jonathan Audet, Yvon Deschambault, Robert Vendramelli, Jessica Prado-Smith, Kevin Tierney, Kimberly Azaransky, Darwyn Kobasa, Chad S. Clancy, Heinz Feldmann, Kyle Rosenke, David Safronetz   +13 more
doaj   +1 more source

Viral hemorrhagic fevers Lassa virus: (Week 27) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending July 8, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Lassa virus, Viral hemorrhagic fevers cases.

core  

Viral hemorrhagic fevers Lassa virus: (Week 13) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending April 1, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Lassa virus, Viral hemorrhagic fevers cases.

core